0001741495-25-000004.txt : 20251020 0001741495-25-000004.hdr.sgml : 20251020 20251020130714 ACCESSION NUMBER: 0001741495-25-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251020 DATE AS OF CHANGE: 20251020 EFFECTIVENESS DATE: 20251020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vergent Bioscience, Inc. CENTRAL INDEX KEY: 0001741495 ORGANIZATION NAME: EIN: 813015243 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-561371 FILM NUMBER: 251403127 BUSINESS ADDRESS: STREET 1: 5810 W 78TH ST STREET 2: STE 222 CITY: MINNEAPOLIS STATE: MN ZIP: 55439 BUSINESS PHONE: 9524263772 MAIL ADDRESS: STREET 1: 5810 W 78TH ST STREET 2: STE 222 CITY: MINNEAPOLIS STATE: MN ZIP: 55439 D 1 primary_doc.xml X0708 D LIVE 0001741495 Vergent Bioscience, Inc. 5810 W 78TH ST STE 222 MINNEAPOLIS MN MINNESOTA 55439 9524263772 DELAWARE Intracellular Technologies, LLC In Vivo Tracer Technologies, LLC In Vivo Technologies, LLC None Corporation true John T. Santini, Jr. c/o Vergent Bioscience, Inc. 5810 West 78th Street, Suite 222 Minneapolis MN MINNESOTA 55439 Executive Officer Director Douglas Kohrs c/o Vergent Bioscience, Inc. 5810 West 78th Street, Suite 222 Minneapolis MN MINNESOTA 55439 Director Raymond Wong c/o Vergent Bioscience, Inc. 5810 West 78th Street, Suite 222 Minneapolis MN MINNESOTA 55439 Director Bobby Helmedag c/o Vergent Bioscience, Inc. 5810 West 78th Street, Suite 222 Minneapolis MN MINNESOTA 55439 Director Anita Watkins c/o Vergent Bioscience, Inc. 5810 West 78th Street, Suite 222 Minneapolis MN MINNESOTA 55439 Director Jeffrey Yurecko c/o Vergent Bioscience, Inc. 5810 West 78th Street, Suite 222 Minneapolis MN MINNESOTA 55439 Executive Officer Biotechnology Decline to Disclose 06b false 2025-10-07 false true true true false 0 31957273 18673277 13283996 Amounts include securities issued upon conversion of outstanding promissory notes and warrants authorized for issuance in connection with the offering. false 20 0 true 0 0 false Vergent Bioscience, Inc. /s/ John T. Santini, Jr. John T. Santini, Jr. President 2025-10-20